Drug Companies Using Delay Tactic to Control the Narrative about High Drug Prices

A pattern is emerging among the drug companies willing to trumpet their pricing on approval day and those that make the market wait. Read article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.